Evidence map›Paper›PMID 38390630›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2024

GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians.

Oluwadamilola Omolara Ojo, Sara Bandres-Ciga, Mary B Makarious, Peter Wild Crea, Dena G Hernandez, Henry Houlden, Mie Rizig, Andrew B Singleton, Alastair J Noyce, Mike A Nalls and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.Movement disorders : official journal of the Movement Disorder Society · 2025
    Pooled it
  2. Article
  3. Behavioral disorders in Parkinson disease: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  4. Article
  5. Review
  6. International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Oluwadamilola Omolara OjoCollege of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria.ORCID 0000-0001-6461-2653
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-0056-1361
Mary B MakariousLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-7978-1051
Peter Wild CreaLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-8944-5716
Dena G HernandezLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-0188-9927
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.ORCID 0000-0002-2866-7777
Mie RizigDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.ORCID 0000-0003-2420-4449
Andrew B SingletonCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-5606-700X
Alastair J NoyceCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University London, London, United Kingdom.ORCID 0000-0003-3027-5497
Mike A NallsCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-0319-4325
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0001-9358-8111
Njideka Ulunma OkubadejoCollege of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria.ORCID 0000-0003-2975-8803
Nigeria Parkinson's Disease Research Network and the Global Parkinson's Genetics Program (GP2)
National Institutes of Health · USLagos State University · NGNational Hospital for Neurology and Neurosurgery · GBQueen Mary University of London · GB

Funding

Genome wide SNP analysis in Parkinson's diseaseZIAAG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.6M
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and GeneticsR01NS125294 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI DEBORAH A HALL, LISA M. SHULMAN · 2022 to 2026
$3.2M
Intramural NIH HHS Z99 AG999999NINDS NIH HHS R01 NS125294
6 · The paper itself

Abstract

backgroundRapid eye movement (REM) sleep behavior disorder (RBD) is an early feature of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Damaging coding variants in Glucocerebrosidase (GBA1) are a genetic risk factor for RBD. Recently, a population-specific non-coding risk variant (rs3115534) was found to be associated with PD risk and earlier onset in individuals of African ancestry.

objectivesWe aimed to investigate whether the GBA1 rs3115534 PD risk variant is associated with RBD in persons with PD.

methodsWe studied 709 persons with PD and 776 neurologically healthy controls from Nigeria. All DNA samples were genotyped and imputed, and the GBA1 rs3115534 risk variant was extracted. The RBD screening questionnaire (RBDSQ) was used to assess symptoms of possible RBD.

resultsRBD was present in 200 PD (28.2%) and 51 (6.6%) controls. We identified that the non-coding GBA1 rs3115534 risk variant is associated with possible RBD in individuals of Nigerian origin (β, 0.3640; standard error [SE], 0.103, P = 4.093e-04), as well as in all samples after adjusting for PD status (β, 0.2542; SE, 0.108; P = 0.019) suggesting that although non-coding, this variant may have the same downstream consequences as GBA1 coding variants.

conclusionsOur results indicate that the non-coding GBA1 rs3115534 risk variant is associated with an increasing number of RBD symptoms in persons with PD of Nigerian origin. Further research is needed to assess if this variant is also associated with polysomnography-defined RBD and with RBD symptoms in DLB. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

GlucosylceramidaseParkinson DiseaseREM Sleep Behavior DisorderWest African PeopleAdultAgedAged, 80 and overFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedNigeriaPolymorphism, Single NucleotideYoung AdultGBA protein, humanGlucosylceramidaseGBA1geneticsNigeriansParkinson's diseaseREM sleep behavior disorderrs3115534

Identifiers

PMID38390630
PMCPMC12164542
OpenAlexW4392110015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.